Cargando…
Reporting of Drug Expenditures in the MCBS
Comparing data from both the 1999 MCBS and drug utilization data supplied by the survey respondents' pharmacies, the author details the methods used to determine the level of misreporting of drug expenditures in the MCBS. Findings suggest that prescription drug expenditures are underreported by...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CENTERS for MEDICARE & MEDICAID SERVICES
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194806/ https://www.ncbi.nlm.nih.gov/pubmed/15124375 |
_version_ | 1782339190642442240 |
---|---|
author | Poisal, John A. |
author_facet | Poisal, John A. |
author_sort | Poisal, John A. |
collection | PubMed |
description | Comparing data from both the 1999 MCBS and drug utilization data supplied by the survey respondents' pharmacies, the author details the methods used to determine the level of misreporting of drug expenditures in the MCBS. Findings suggest that prescription drug expenditures are underreported by 17 percent and the number of prescriptions used is underreported by 17.7 percent. The data also identify demographic factors that predict a beneficiary's likelihood to either overreport or underreport his or her medications, as well as the extent to which beneficiaries misreport their drug use and spending. |
format | Online Article Text |
id | pubmed-4194806 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | CENTERS for MEDICARE & MEDICAID SERVICES |
record_format | MEDLINE/PubMed |
spelling | pubmed-41948062014-11-04 Reporting of Drug Expenditures in the MCBS Poisal, John A. Health Care Financ Rev Research Article Comparing data from both the 1999 MCBS and drug utilization data supplied by the survey respondents' pharmacies, the author details the methods used to determine the level of misreporting of drug expenditures in the MCBS. Findings suggest that prescription drug expenditures are underreported by 17 percent and the number of prescriptions used is underreported by 17.7 percent. The data also identify demographic factors that predict a beneficiary's likelihood to either overreport or underreport his or her medications, as well as the extent to which beneficiaries misreport their drug use and spending. CENTERS for MEDICARE & MEDICAID SERVICES 2003 /pmc/articles/PMC4194806/ /pubmed/15124375 Text en |
spellingShingle | Research Article Poisal, John A. Reporting of Drug Expenditures in the MCBS |
title | Reporting of Drug Expenditures in the MCBS |
title_full | Reporting of Drug Expenditures in the MCBS |
title_fullStr | Reporting of Drug Expenditures in the MCBS |
title_full_unstemmed | Reporting of Drug Expenditures in the MCBS |
title_short | Reporting of Drug Expenditures in the MCBS |
title_sort | reporting of drug expenditures in the mcbs |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194806/ https://www.ncbi.nlm.nih.gov/pubmed/15124375 |
work_keys_str_mv | AT poisaljohna reportingofdrugexpendituresinthemcbs |